Ipca Laboratories Limited (IPCALAB.NS)
INR 1301.05
(-7.02%)
INR 1301.05
(-7.02%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 5.8 Billion INR | -13.22% |
| 2022 | 6.68 Billion INR | 64.47% |
| 2021 | 4.06 Billion INR | 807.97% |
| 2020 | 447.9 Million INR | -61.38% |
| 2019 | 1.15 Billion INR | -17.65% |
| 2018 | 1.4 Billion INR | -39.81% |
| 2017 | 2.34 Billion INR | -33.47% |
| 2016 | 3.51 Billion INR | -27.96% |
| 2015 | 4.88 Billion INR | -2.96% |
| 2014 | 5.03 Billion INR | 71.16% |
| 2013 | 2.94 Billion INR | -19.72% |
| 2012 | 3.66 Billion INR | 10.91% |
| 2011 | 3.3 Billion INR | -37.8% |
| 2010 | 5.3 Billion INR | 16.79% |
| 2009 | 4.54 Billion INR | -1.18% |
| 2008 | 4.59 Billion INR | 30.29% |
| 2007 | 3.53 Billion INR | 47.74% |
| 2006 | 2.38 Billion INR | 21.35% |
| 2005 | 1.96 Billion INR | -10.8% |
| 2004 | 2.2 Billion INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q2 | 7.27 Billion INR | 0.0% |
| 2023 FY | 5.8 Billion INR | -13.22% |
| 2023 Q4 | 5.8 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 4.42 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 6.68 Billion INR | 0.0% |
| 2022 FY | 6.68 Billion INR | 64.47% |
| 2021 Q4 | 4.06 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 126.5 Million INR | 0.0% |
| 2021 FY | 4.06 Billion INR | 807.97% |
| 2020 Q4 | 447.9 Million INR | 0.0% |
| 2020 FY | 447.9 Million INR | -61.38% |
| 2020 Q2 | 783.1 Million INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 FY | 1.15 Billion INR | -17.65% |
| 2019 Q4 | 1.15 Billion INR | 0.0% |
| 2019 Q2 | 1.35 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 Q4 | 1.4 Billion INR | 0.0% |
| 2018 FY | 1.4 Billion INR | -39.81% |
| 2018 Q1 | - INR | 0.0% |
| 2017 FY | 2.34 Billion INR | -33.47% |
| 2016 FY | 3.51 Billion INR | -27.96% |
| 2015 FY | 4.88 Billion INR | -2.96% |
| 2014 FY | 5.03 Billion INR | 71.16% |
| 2013 FY | 2.94 Billion INR | -19.72% |
| 2012 FY | 3.66 Billion INR | 10.91% |
| 2011 FY | 3.3 Billion INR | -37.8% |
| 2010 FY | 5.3 Billion INR | 16.79% |
| 2009 FY | 4.54 Billion INR | -1.18% |
| 2008 FY | 4.59 Billion INR | 30.29% |
| 2007 FY | 3.53 Billion INR | 47.74% |
| 2006 FY | 2.38 Billion INR | 21.35% |
| 2005 FY | 1.96 Billion INR | -10.8% |
| 2004 FY | 2.2 Billion INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 628.8 Million INR | -823.044% |
| Bafna Pharmaceuticals Limited | 107.53 Million INR | -5297.556% |
| FDC Limited | 2.46 Million INR | -235264.964% |
| Gufic Biosciences Limited | 1.53 Billion INR | -276.98% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 81.674% |
| Nectar Lifesciences Limited | 1.4 Billion INR | -313.666% |
| Orchid Pharma Limited | 1.2 Billion INR | -381.949% |
| Alkem Laboratories Limited | 400 Million INR | -1351.025% |
| Bajaj HealthCare Limited | 650.34 Million INR | -792.465% |
| Brooks Laboratories Limited | 3.56 Million INR | -162707.854% |
| Eris Lifesciences Limited | 6.54 Billion INR | 11.321% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -3832.051% |
| Solara Active Pharma Sciences Limited | 1.17 Billion INR | -394.218% |
| Innova Captab Limited | 2.1 Billion INR | -175.703% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -7580.429% |
| Wanbury Limited | 820 Million INR | -607.817% |
| Lupin Limited | 1.55 Billion INR | -273.783% |
| Aarti Drugs Limited | 2.75 Billion INR | -110.805% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -1450925.0% |
| Albert David Limited | 6.01 Million INR | -96377.726% |
| Alembic Limited | 73.9 Million INR | -7753.992% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Hester Biosciences Limited | 1.81 Billion INR | -219.305% |
| Hikal Limited | 4.22 Billion INR | -37.261% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -5099.595% |
| Ind-Swift Limited | 10.09 Billion INR | 42.505% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Lincoln Pharmaceuticals Limited | - INR | -Infinity% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -4246.306% |
| Medico Remedies Limited | 8.67 Million INR | -66829.197% |
| Morepen Laboratories Limited | 33.64 Million INR | -17153.567% |
| Procter & Gamble Health Limited | 68.8 Million INR | -8336.192% |
| RPG Life Sciences Limited | -30.3 Million INR | 19255.446% |
| Sigachi Industries Limited | 265.79 Million INR | -2083.651% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -43539.85% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -2633.193% |
| Themis Medicare Limited | 267.74 Million INR | -2067.812% |
| Unichem Laboratories Limited | 382.22 Million INR | -1418.519% |
| Vaishali Pharma Limited | 35.98 Million INR | -16030.117% |
| Venus Remedies Limited | 386.8 Million INR | -1400.543% |
| Windlas Biotech Limited | 20.18 Million INR | -28661.645% |
| ZIM Laboratories Limited | 356 Million INR | -1530.338% |
| Sakar Healthcare Limited | 549.55 Million INR | -956.155% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 72.813% |
| Divi's Laboratories Limited | 20 Million INR | -28920.5% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -20751.056% |
| Mankind Pharma Limited | 325.81 Million INR | -1681.41% |
| Sequent Scientific Limited | 1.42 Billion INR | -306.68% |
| Laurus Labs Limited | 7.98 Billion INR | 27.288% |
| Neuland Laboratories Limited | 449.2 Million INR | -1192.08% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -2355.203% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | -282.627% |
| Zydus Lifesciences Limited | 251 Million INR | -2212.39% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -41452.835% |
| Wockhardt Limited | 8.91 Billion INR | 34.859% |
| Bal Pharma Limited | 363.82 Million INR | -1495.304% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | 3.104% |
| Bliss GVS Pharma Limited | 355.92 Million INR | -1530.722% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 9.2 Million INR | -62988.043% |
| Shilpa Medicare Limited | 5.6 Billion INR | -3.615% |
| Valiant Laboratories Limited | 750.89 Million INR | -672.953% |
| Ajanta Pharma Limited | 235.2 Million INR | -2367.73% |
| Aarey Drugs & Pharmaceuticals Limited | 32.24 Million INR | -17900.689% |
| Granules India Limited | 689.71 Million INR | -741.528% |
| Medicamen Biotech Limited | 12.55 Million INR | -46129.391% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 476236.177% |
| Piramal Enterprises Limited | 535.85 Billion INR | 98.917% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | 63.815% |
| NATCO Pharma Limited | 53 Million INR | -10851.132% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | -216.3% |
| Strides Pharma Science Limited | 6.71 Billion INR | 13.565% |
| Indoco Remedies Limited | 3.51 Billion INR | -65.016% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -5344.747% |